Spotlight
Clinical
CME/CE
Study challenges thinking on PCa in African-Americans
Bethesda, MD-A new study suggests that, even though there is growing evidence that genetic factors impacting hormonal regulation of aggressive prostate cancer are more frequent among African-Americans than other ethnic groups, differences in disease-free survival can be eliminated.
Related Videos
Related Content
Dr. Schuster highlights the FDA approval of imaging agent flotufolastat F 18 in prostate cancer
June 22nd 2023Podcast
"We're excited that the FDA approval of this radiotracer gives us yet more tools at our disposal to diagnose prostate cancer in all its forms, from early to late in the disease process," says David M. Schuster, MD, FACR.
